Global Flow Cytometry In Oncology And Immunology Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Flow Cytometry In Oncology And Immunology Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Flow Cytometry In Oncology And Immunology Market Size and Projected Growth Rate?
The oncology and immunology market for flow cytometry has experienced swift expansion in the past few years. Projected to rise from $2.11 billion in 2024 to $2.33 billion in 2025, it has a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the growth during the historic period include progress in cancer research, an increase in immunology research, diagnostic applications, the prevalence of autoimmune diseases, and advances in drug development and clinical trials.

The market size for flow cytometry in oncology and immunology is predicted to experience a significant escalation in the coming years, expanding to $3.46 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%. The anticipated growth during the forecast period can be ascribed to the incorporation of genomics and proteomics, the increasing use of single-cell analysis, the growing applications in dealing with infectious diseases, the upsurge in cancer incidences, and the implementation of flow cytometry at point-of-care locations. The expected trends for the forecast period comprise immunophenotyping for immunotherapy, flow cytometry systems' miniaturization, multiparametric analysis, a shift towards spectral flow cytometry, and cooperative research efforts.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469

What Are the Major Segments in the Flow Cytometry In Oncology And Immunology Market?
The flow cytometry in oncology and immunology market covered in this report is segmented -

1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Are The Driving Flow Cytometry In Oncology And Immunology Market Evolution?
The rising rates of cancer are anticipated to fuel the expansion of flow cytometry within the oncology and immunology market. Cancer, a condition encompassing a set of disorders defined by the unchecked multiplication and dissemination of abnormal cells in the body, is driving the widespread use of flow cytometry in oncology and immunology for examining cancerous and immune cells. For example, in Macmillan Cancer Support, a health charity based in the UK, the number of cancer patients stood at 3 million in 2020, and predictions suggest an increase to 3.5 million by 2025, then 4 million by 2030, and eventually reaching 5.3 million by 2040. Consequently, the escalating trends of cancer are propelling the rise of flow cytometry in the oncology and immunology sectors.

Which Firms Dominate The Flow Cytometry In Oncology And Immunology Market Segments?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton inson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

What Trends Are Expected to Dominate the Flow Cytometry In Oncology And Immunology Market in the Next 5 Years?
Emerging technology is a significant trend gaining traction in the oncology and immunology flow cytometry market. Established firms in this sector are embracing innovative technologies to maintain their market presence. Becton inson and Company, a renowned medical technology firm in the US, unveiled BD Research Cloud for flow cytometry in oncology and immunology in September 2022. BD Cloud, a cloud-based software system, streamlines the flow cytometry process for researchers in varied disciplines, such as immunology, virology, infectious diseases, and oncology surveillance, stimulating high-quality studies with faster insights. BD employs innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the recently launched BD FACSDiscover S8 Cell Sorter coupled with BD CellView Image Technology, to amplify flow cytometry capabilities, facilitating researchers to enhance and progress their pioneering studies. Designed on a standard cloud infrastructure, BD Research Cloud is exclusively suited for BD equipment and reagents.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Which Is The Largest Region In The Flow Cytometry In Oncology And Immunology Market?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Flow Cytometry In Oncology And Immunology Market?
2. What is the CAGR expected in the Flow Cytometry In Oncology And Immunology Market?
3. What Are the Key Innovations Transforming the Flow Cytometry In Oncology And Immunology Industry?
4. Which Region Is Leading the Flow Cytometry In Oncology And Immunology Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.